全身性与腹型肥胖及新发远端感觉运动多发性神经病变:KORA F4/FF4队列中炎症生物标志物作为潜在中介的启示
在KORA F4/FF4队列513名62-81岁参与者中,平均随访6.5年后127例发生远端感觉运动多发性神经病变(DSPN)。全身性与腹型肥胖均与DSPN发生相关,且此关联不受糖尿病状态影响,部分由炎症标志物CCL7、CXCL10和DNER介导。
要点
- 超重和肥胖者DSPN风险显著增高,腰围每增加5cm风险亦升高。
- 肥胖与DSPN的关联在糖尿病和非糖尿病人群中无差异。
- CCL7、CXCL10和DNER部分介导该关联,但大部分效应仍未解释。
核心结论
- 全身性和腹型肥胖均与新发DSPN相关,且该关联部分由亚临床炎症标志物介导。
研究设计与样本
- 基于KORA F4/FF4队列的513名62-81岁参与者,基线测量人体测量学指标,随访平均6.5年,用密歇根神经病变筛查仪定义新发DSPN。
主要发现
- 随访期间127例发生DSPN。
- 与正常BMI相比,超重者DSPN的OR为3.06(95%CI 1.57-5.97),肥胖者为3.47(95%CI 1.72-7.00)。
- 腰围每增加5cm,DSPN的OR为1.22(95%CI 1.07-1.38)。
- 交互分析未显示糖尿病状态对上述关联有差异。
- CCL7、CXCL10和DNER被鉴定为潜在中介,每个标志物解释总效应的比例最高达11%。
临床怎么用
- 在内分泌科临床中,应关注超重和肥胖患者(无论是否合并糖尿病)的DSPN筛查。
- 腰围增加可作为DSPN风险的简易预警指标。
- 炎症标志物可能为未来干预提供靶点,但目前尚不能用于常规风险分层。
局限性
- 需要进一步研究其他机制和生物标志物以解释剩余关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the associations between different anthropometric measurements and development of distal sensorimotor polyneuropathy (DSPN) considering interaction effects with prediabetes/diabetes and to evaluate subclinical inflammation as a potential mediator. RESEARCH DESIGN AND METHODS: This study was conducted among 513 participants from the Cooperative Health Research in the Region of Augsburg (KORA) F4/FF4 cohort (aged 62-81 years). Anthropometry was measured at baseline. Incident DSPN was defined by neuropathic impairments using the Michigan Neuropathy Screening Instrument at baseline and follow-up. Associations between anthropometric measurements and DSPN were estimated by multivariable logistic regression. Potential differences by diabetes status were assessed using interaction terms. Mediation analysis was conducted to determine the mediation effect of subclinical inflammation in these associations. RESULTS: After a mean follow-up of 6.5 years, 127 cases with incident DSPN were detected. Both general and abdominal obesity were associated with development of DSPN. The odds ratios (95% CI) of DSPN were 3.06 (1.57; 5.97) for overweight, 3.47 (1.72; 7.00) for obesity (reference: normal BMI), and 1.22 (1.07; 1.38) for 5-cm differences in waist circumference, respectively. Interaction analyses did not indicate any differences by diabetes status. Two chemokines (C-C motif chemokine ligand 7 [CCL7] and C-X-C motif chemokine ligand 10 [CXCL10]) and one neuron-specific marker (Delta/Notch-like epidermal growth factor-related receptor [DNER]) were identified as potential mediators, which explained a proportion of the total effect up to 11% per biomarker. CONCLUSIONS: General and abdominal obesity were associated with incident DSPN among individuals with and without diabetes, and this association was partly mediated by inflammatory markers. However, further mechanisms and biomarkers should be investigated as additional mediators to explain the remainder of this association.
引用
- Schlesinger S, Herder C, Kannenberg JM, et al. General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort. Diabetes Care. 2018. PMID: 30523031. doi:10.2337/dc18-1842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。